DE69800357D1 - Feste, nicht zerfliessbare formulierung von natrium valproat - Google Patents

Feste, nicht zerfliessbare formulierung von natrium valproat

Info

Publication number
DE69800357D1
DE69800357D1 DE69800357T DE69800357T DE69800357D1 DE 69800357 D1 DE69800357 D1 DE 69800357D1 DE 69800357 T DE69800357 T DE 69800357T DE 69800357 T DE69800357 T DE 69800357T DE 69800357 D1 DE69800357 D1 DE 69800357D1
Authority
DE
Germany
Prior art keywords
sodium
valproat
solid
flowable formulation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69800357T
Other languages
English (en)
Other versions
DE69800357T2 (de
Inventor
Karin Klokkers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hexal AG
Original Assignee
Hexal AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal AG filed Critical Hexal AG
Application granted granted Critical
Publication of DE69800357D1 publication Critical patent/DE69800357D1/de
Publication of DE69800357T2 publication Critical patent/DE69800357T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Nanotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69800357T 1997-03-11 1998-03-11 Feste, nicht zerfliessbare formulierung von natrium valproat Expired - Fee Related DE69800357T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HUP9707337 1997-03-11
PCT/EP1998/001404 WO1998040060A1 (en) 1997-03-11 1998-03-11 Solid, non-deliquescent formulations of sodium valproate

Publications (2)

Publication Number Publication Date
DE69800357D1 true DE69800357D1 (de) 2000-11-23
DE69800357T2 DE69800357T2 (de) 2001-05-17

Family

ID=89575042

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69800357T Expired - Fee Related DE69800357T2 (de) 1997-03-11 1998-03-11 Feste, nicht zerfliessbare formulierung von natrium valproat

Country Status (9)

Country Link
US (1) US6204255B1 (de)
EP (1) EP0921793B1 (de)
JP (1) JP2000510874A (de)
AT (1) ATE196992T1 (de)
AU (1) AU727521B2 (de)
CA (1) CA2254078A1 (de)
DE (1) DE69800357T2 (de)
DK (1) DK0921793T3 (de)
WO (1) WO1998040060A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5420126B2 (ja) * 1999-02-04 2014-02-19 アボット・ラボラトリーズ ｐＨ非依存延長放出性医薬組成物
AT408718B (de) * 1999-12-02 2002-02-25 Gerot Pharmazeutika Natriumvalproat-granulat mit verringerter hygroskopizität
US20020127277A1 (en) * 2000-12-22 2002-09-12 Yihong Qiu Solid dosage forms of divalproex sodium
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20030180249A1 (en) * 2002-03-18 2003-09-25 Khanna Satish Chandra Dosage forms for hygroscopic active ingredients
CA2413834A1 (en) * 2002-12-10 2004-06-10 1017975 Alberta Limited Nitric oxide gas generator
US20090028937A1 (en) * 2005-01-31 2009-01-29 Kyowa Hakko Kogyo Co., Ltd. Tablet comprising ornithine hydrochloride
CN101444494B (zh) * 2008-12-31 2011-03-30 江苏大学 难溶性药物高效长效缓释制剂及其制法
US20100204325A1 (en) * 2009-02-11 2010-08-12 Allergan, Inc. Valproic acid drug delivery systems and intraocular therapeutic uses thereof
JP2015054829A (ja) * 2013-09-10 2015-03-23 ハウス食品グループ本社株式会社 複合体の造粒物及びその製造方法
WO2023225119A1 (en) * 2022-05-18 2023-11-23 Pliant Therapeutics, Inc. Stabilization of integrin inhibitors
CN115154424A (zh) * 2022-06-01 2022-10-11 广州茂丰药业有限公司 一种含丙戊酸钠盐低引湿性固体分散体及其制备方法、以及缓释片片芯

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56133236A (en) * 1980-03-22 1981-10-19 Kyowa Hakko Kogyo Co Ltd Sodium valproate clathrate
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
WO1995013794A1 (fr) * 1993-11-18 1995-05-26 Nippon Shinyaku Co., Ltd. Procede pour produire une composition de medicament stable, et preparation pharmaceutique

Also Published As

Publication number Publication date
DK0921793T3 (da) 2000-12-18
AU727521B2 (en) 2000-12-14
US6204255B1 (en) 2001-03-20
JP2000510874A (ja) 2000-08-22
EP0921793A1 (de) 1999-06-16
CA2254078A1 (en) 1998-09-17
ATE196992T1 (de) 2000-11-15
DE69800357T2 (de) 2001-05-17
AU7033698A (en) 1998-09-29
WO1998040060A1 (en) 1998-09-17
EP0921793B1 (de) 2000-10-18

Similar Documents

Publication Publication Date Title
TR28442A (tr) Selüloz-esasli bir ön-karisimin olusturulmasi.
DE68919745T2 (de) Wässerige Beschichtungszusammensetzungen.
PT977741E (pt) Derivados de fenilo substituido, sua preparacao e utilizacao
HN1999000155A (es) 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas
DE69810900T2 (de) Agrochemische zusammensetzungen von oberflächenaktiven verbindungen
DE69841129D1 (de) Oszillierendes Reibschweisprodukt
DE69410628D1 (de) Wasserlösliche organosiloxanverbindungen
DE69203396D1 (de) Nachgiebige Abstreichklinge.
PT1019358E (pt) 3,3-diarilpropilaminas sua utilizacao e sua preparacao
DE69800357T2 (de) Feste, nicht zerfliessbare formulierung von natrium valproat
HN1998003689A (es) Azetidinas
DE69202164D1 (de) Stabilisierung von Thiolenzusammensetzungen.
DK0972024T3 (da) Tumorsuppressor designeret TS10Q23.3
DE58901357D1 (de) Schleuderduengerstreuer.
DE59609043D1 (de) Feste Lösungen von 1,4-Diketopyrrolopyrrolen
DE69003075T2 (de) Stabilisierungszusammensetzungen.
HN1998000045A (es) Composiciones farmaceuticas
DK0768304T3 (da) Hidtil ukendte sulfonamider
FR2715944B1 (fr) Support latéral d'une lame.
DE69208681D1 (de) Verwendungen von 1,1,1,3,3,3-hexafluoropropan
DE69611800D1 (de) Von azlactonen abgeleitete tenside
DE58901649D1 (de) Schleuderduengerstreuer.
TR199901535A2 (en) Siklooksigenaz �nleyicisi.
DE59006429D1 (de) Gasreibungspumpe.
NO900706L (no) Pentamidinopploesninger.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee